Staar Surgical Shares Rise After Swing to 1Q Profit

Dow Jones05-15

By Christopher Kuo

Staar Surgical shares climbed after the company swung to a first-quarter profit amid a surge in revenue.

Shares of the medical-device company rose 11% on Thursday to $32.76 after reaching a new 52-week high of $35.87 earlier in the session. The stock is up 41% year to date.

The company reported a first-quarter profit of $5.21 million, or 10 cents a share, compared with a loss of $54.2 million, or $1.10 a share, a year earlier. Analysts polled by FactSet expected a loss of 5 cents a share.

Sales more than doubled to $93.5 million. Analysts expected $78.7 million. The growth in sales was driven by strong performance in China, including a successful launch of its implantable contact lens for nearsightedness and astigmatism, Staar said. The company also reported double-digit growth in the Americas. In the U.S., sales growth reflected increased surgeon adoption and improved commercial execution, the company said.

Staar said its operating expenses fell to $60.9 million from $85.4 million in the prior year. The company reduced its general and administrative expenses and its selling and marketing expenses, it said.

Write to Christopher Kuo at chris.kuo@wsj.com

(END) Dow Jones Newswires

May 14, 2026 12:55 ET (16:55 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635574498?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 00:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635574498","market":"sg","top_or_hot":-1,"title":"Staar Surgical Shares Rise After Swing to 1Q Profit","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Christopher Kuo \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Staar Surgical shares climbed after the company swung to a first-quarter profit amid a surge in revenue. \n</p>\n<p>\n  Shares of the medical-device company rose 11% on Thursday to $32.76 after reaching a new 52-week high of $35.87 earlier in the session. The stock is up 41% year to date. \n</p>\n<p>\n  The company reported a first-quarter profit of $5.21 million, or 10 cents a share, compared with a loss of $54.2 million, or $1.10 a share, a year earlier. Analysts polled by FactSet expected a loss of 5 cents a share. \n</p>\n<p>\n  Sales more than doubled to $93.5 million. Analysts expected $78.7 million. The growth in sales was driven by strong performance in China, including a successful launch of its implantable contact lens for nearsightedness and astigmatism, Staar said. The company also reported double-digit growth in the Americas. In the U.S., sales growth reflected increased surgeon adoption and improved commercial execution, the company said. \n</p>\n<p>\n  Staar said its operating expenses fell to $60.9 million from $85.4 million in the prior year. The company reduced its general and administrative expenses and its selling and marketing expenses, it said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Christopher Kuo at chris.kuo@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 14, 2026 12:55 ET (16:55 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Staar Surgical Shares Rise After Swing to 1Q Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStaar Surgical Shares Rise After Swing to 1Q Profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-15 00:55</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Christopher Kuo \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Staar Surgical shares climbed after the company swung to a first-quarter profit amid a surge in revenue. \n</p>\n<p>\n  Shares of the medical-device company rose 11% on Thursday to $32.76 after reaching a new 52-week high of $35.87 earlier in the session. The stock is up 41% year to date. \n</p>\n<p>\n  The company reported a first-quarter profit of $5.21 million, or 10 cents a share, compared with a loss of $54.2 million, or $1.10 a share, a year earlier. Analysts polled by FactSet expected a loss of 5 cents a share. \n</p>\n<p>\n  Sales more than doubled to $93.5 million. Analysts expected $78.7 million. The growth in sales was driven by strong performance in China, including a successful launch of its implantable contact lens for nearsightedness and astigmatism, Staar said. The company also reported double-digit growth in the Americas. In the U.S., sales growth reflected increased surgeon adoption and improved commercial execution, the company said. \n</p>\n<p>\n  Staar said its operating expenses fell to $60.9 million from $85.4 million in the prior year. The company reduced its general and administrative expenses and its selling and marketing expenses, it said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Christopher Kuo at chris.kuo@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 14, 2026 12:55 ET (16:55 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2635574498","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635574498","pubTimestamp":1778777700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Staar Surgical shares climbed after the company swung to a first-quarter profit amid a surge in revenue.Shares of the medical-device company rose 11% on Thursday to $32.76 after reaching a new 52-week high of $35.87 earlier in the session. The stock is up 41% year to date.The company reported a first-quarter profit of $5.21 million, or 10 cents a share, compared with a loss of $54.2 million, or $1.10 a share, a year earlier. Analysts polled by FactSet expected a loss of 5 cents a share.Sales more than doubled to $93.5 million. Analysts expected $78.7 million. The growth in sales was driven by strong performance in China, including a successful launch of its implantable contact lens for nearsightedness and astigmatism, Staar said. The company also reported double-digit growth in the Americas. In the U.S., sales growth reflected increased surgeon adoption and improved commercial execution, the company said.Staar said its operating expenses fell to $60.9 million from $85.4 million in the ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","STAA":"STAAR Surgical Company"},"translate_title":"Staar Surgical股价在第一季度扭亏为盈后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1.5},"content_text":"By Christopher Kuo \n\n\n \n\n\n  Staar Surgical shares climbed after the company swung to a first-quarter profit amid a surge in revenue. \n\n\n  Shares of the medical-device company rose 11% on Thursday to $32.76 after reaching a new 52-week high of $35.87 earlier in the session. The stock is up 41% year to date. \n\n\n  The company reported a first-quarter profit of $5.21 million, or 10 cents a share, compared with a loss of $54.2 million, or $1.10 a share, a year earlier. Analysts polled by FactSet expected a loss of 5 cents a share. \n\n\n  Sales more than doubled to $93.5 million. Analysts expected $78.7 million. The growth in sales was driven by strong performance in China, including a successful launch of its implantable contact lens for nearsightedness and astigmatism, Staar said. The company also reported double-digit growth in the Americas. In the U.S., sales growth reflected increased surgeon adoption and improved commercial execution, the company said. \n\n\n  Staar said its operating expenses fell to $60.9 million from $85.4 million in the prior year. The company reduced its general and administrative expenses and its selling and marketing expenses, it said. \n\n\n \n\n\n  Write to Christopher Kuo at chris.kuo@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 12:55 ET (16:55 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635574498","isCrawlerRequest":true}